全基因组评估揭示了同胞性模式的祖先差异,可能与帕金森病病因相关
Kathryn Step1,2, Carlos F Hernández3, Marzieh Khani4
1Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
概括
同胞性 (ROH) 的运行有助于帕金森病 (PD) 在不同人群中的遗传性,揭示了对疾病风险和发病时的年龄的衰退性遗传影响. 需要进一步的研究来确定特定的罕见衰退变异.
科学领域:
- 遗传学 遗传学 是一个
- 神经退行性疾病 神经退行性疾病
- 人口遗传学 人口遗传学
背景情况:
- 衰退性遗传变异和长期的同卵性性 (ROHs) 与帕金森病 (PD) 无法解释的遗传性有关.
- 多样化和研究不足的人群可能存在对PD的独特遗传贡献.
研究的目的:
- 调查全基因组同卵性对PD风险和发病时的年龄 (AAO) 在一个大型多祖先队列中的影响.
- 确定新型的同卵性区域,有助于PD遗传性.
主要方法:
- 对同胞性 (ROH) 运行的分析,包括总长度 (SROH),数量 (NROH),平均长度 (AVROH) 和基因组内生育系数 (FROH).
- ROHs与已知的PD基因区域和风险位置的交叉.
- 同胞性映射用于识别ROH在家庭,血缘亲属个体和早期发病的PD (EOPD) 病例中的重叠.
主要成果:
- 在祖先之间的PD病例和对照之间观察到ROH指标 (SROH,AVROH,NROH,FROH) 的显著差异.
- 独特的ROH丰富模式与AAO有关,这表明PD的衰退性遗传修饰剂.
- 同血亲个体和EOPD病例中的1559个ROH重叠了已知的PD基因区域和风险位置.
结论:
- ROH区域有助于跨祖先的PD遗传性,反映出部分衰退的遗传结构.
- 需要进行更大规模,更多样化的全基因组测序研究,以确定影响PD风险的罕见衰退变异.
相关概念视频
Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
Single Nucleotide Polymorphisms-SNPs
19.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.3K
Principles of Pharmacogenetics: Types of Genetic Variants
69
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
69
Human Genetics
1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Incomplete Dominance
31.9K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
31.9K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K


